CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,910.00
+50.00 (1.30%)
At close: Apr 29, 2026
-43.50%
Market Cap 93.48B
Revenue (ttm) 123.77B
Net Income (ttm) 3.24B
Shares Out 23.91M
EPS (ttm) 136.00
PE Ratio 28.51
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,909
Average Volume 64,524
Open 3,900.00
Previous Close 3,860.00
Day's Range 3,830.00 - 3,915.00
52-Week Range 3,575.00 - 7,680.00
Beta -0.01
RSI 50.18
Earnings Date May 12, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.